Phytomedicine as a source of SGLT2 inhibitors, GLP-1 secretagogues and DPP-IV inhibitors for mitigation of Diabetic Nephropathy
Background: Diabetic nephropathy (DN) has been the major contributor to chronic kidney disease (CKD), end stage renal disease (ESRD), and cardiovascular risks. Incretin pathway modulators (GLP-1 analogs, GLP-1R agonist, GLP-1 secretagogues and DPP-IV inhibitors) and SGLT2 inhibitors are presently th...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2022-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |